Skip to main content

Donald Halbert, Vishal Wanchoo, Eric Lander, Dorian Rinella, Alain Couder, Jussi Harvela, Jeffrey Duggan, Chris Capelli, David Goldstein

Donald Halbert this week was named executive vice president of research and development for Iconix Pharmaceuticals. Halbert was director of genomics, proteomics, and bioinformatics in the global pharmaceutical research and development group of Abbott Laboratories. Additionally, Halbert directed Abbott's toxicogenomics program and oversaw the scientific advisory committee that directed a collaboration between Abbott and Iconix that was initiated in December 2003. Before joining Abbott, Halbert was an executive with Becton Dickinson.


Vishal Wanchoo has been named president and CEO of GE Healthcare's new healthcare information technologies unit, which will develop clinical information technology connecting hospitals, physicians' offices, and patients. Previously, Wanchoo was vice president and general manager for clinical information technology for GE Healthcare.


Eric Lander will receive this year's Public Understanding of Science and Technology award from the American Association for the Advancement of Science, AAAS said last week. He is the founding director of the Broad Institute of MIT and Harvard and a professor of biology at MIT, a professor of systems biology at Harvard Medical School, and a member of the Whitehead Institute for Biomedical Research. Lander holds a PhD in mathematics from Oxford University and an undergraduate degree in mathematics from Princeton University.


Dorian Rinella was appointed vice president of human resources for Corgentech of South San Francisco. Rinella joined the company from a position as vice president for human resources and facilities for Kosan Biosciences of Hayward, Calif. Rinella previously worked for Bio-Rad.


Alain Couder was named president and chief executive officer of Solid Information Technology, a Cupertino, Calif., company that provides emebedded data management for devices. Couder, a member of the company's board of directors since 1999, previously was chief operating officer for Agilent Technologies. He replaces Jussi Harvela, who will become executive vice president of business development and strategy and remain on the board of directors.


Jeffrey Duggan has been named vice president of analytical operations for Midwest BioResearch, the company said. Duggan was head of bioanalytical laboratory at NeoPharm and previously worked at PerkinElmer. Midwest BioResearch of Evanston, Ill., provides services in bioanalysis, structure identification, and genetic toxicology to pharmaceutical and biotechnology companies.


Chris Capelli, technology transfer director of the University of Pittsburgh, has been named vice president for technology at the MD Anderson Cancer Center of the University of Texas.


David Goldstein has been named director for the new Center for Population Genomics and Pharmacogenetics at Duke University. Goldstein, who will have a joint appointment as professor of molecular genetics and microbiology and biology, is leaving a position as professor of genetics at the Galton Laboratory of the department of biology at University College, London.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.